Paper Review Records
全部论文审稿周期
16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
121
天
Event-free survival in patients with early triple-negative breast cancer receiving platinum-free, de-escalated anti-PD-1 neoadjuvant therapy: an updated analysis of the NeoTENNIS trial
作者
Shuang Hao; Xuliren Wang; Lin-Xiaoxi Ma; Min He; Bingqiu Xiu; Benlong Yang; Jiajian Chen; Xiaoyan Huang; Qin Xiao; Yan Huang; Ruo-Hong Shui; A-Yong Cao; Jun-Jie Li; Gen-Hong Di; Wen-Tao Yang; Guang-Yu Liu; Ke-Da Yu; Yi-Zhou Jiang; Zhong-Hua Wang; Zhi-Ming Shao; Jiong Wu展开收起
作者单位
Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China展开收起
199
天
CHK1/2 as a potential therapeutic target in Neurofibromatosis type 2 schwannomas
作者
Dorothy Benton; Ramil Khusnutdinov; Mariia Buts; Mariia Dmitrieva; Daniela Araiza-Olivera; Cristina Uribe-Alvarez; Jonathan Chernoff展开收起
作者单位
Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America; Department of Biochemistry & Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, United States of America; Medical Faculty No. 1, Bogomolets National Medical University, Kyiv, Ukraine展开收起
85
天
Schedule-dependent efficacy of gemcitabine and RAS(ON) inhibition in orthotopic pancreatic cancer: implications for clinical trial design
作者
Kyle P. Gribbin; Hen Halamish; Ivan Rodriguez Siordia; Jennifer M. Finan; Michael J. Pishvaian; Charles D. Lopez; Adel Kardosh; Shaun Goodyear; Rosalie C. Sears; Teresa Zimmers; Aaron Grossberg; Katelyn T. Byrne; Jonathan R. Brody展开收起
作者单位
Department of Surgery, Oregon Health & Science University, Portland, OR, USA; Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Division of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA; Department of Molecular and Medical Genetics, School of Medicine, Oregon Health and Science University, Portland, OR, USA; Department of Radiation Medicine, Oregon Health & Science University, Portland, OR, USA; Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, OR, USA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA展开收起
162
天
A simplified scoring system for predicting total hip arthroplasty in hematologic cancer patients with osteonecrosis of the femoral head following allogeneic hematopoietic stem cell transplantation
作者
Yun He; Peng Zhao; Yejun Wu; Bo Yang; Hu Li; Ke Tao; Tiezheng Sun; Jianhao Lin; Haixia Fu; Qiusha Huang; Xiaolu Zhu; Fengrong Wang; Xiaodong Mo; Yuanyuan Zhang; Wei Han; Huan Chen; Yao Chen; Jun Kong; Zhidong Wang; ChenHua Yan; Jingzhi Wang; Tingting Han; Yuhong Chen; Yuqian Sun; Yingjun Chang; Yu Wang; Lanping Xu; Xiaojun Huang; Xiaohui Zhang展开收起
作者单位
Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; National Clinical Research Center for Hematologic Disease, Beijing, China; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China; Collaborative Innovation Center of Hematology, Peking University, Beijing, China; Peking University People's Hospital, Arthritis Clinical and Research Center, Beijing, China展开收起
153
天
MCM10 modulates lipid metabolic reprogramming via the USP7-FASN axis to accelerate renal cell carcinoma progression
作者
Ashuai Du; Kehua Jiang; Kai Li; Xinpei Deng; Dongbo Yuan; Yuanyuan Luo; Songsong Tan; Xuchao Dai; Bo Yu; Bo Yan; Huichao Huang; Junjie Xu; Yanjun Wang; Jianguo Zhu展开收起
作者单位
Department of Infection, Guizhou Provincial People's Hospital, Guiyang, 550000, China; Guangzhou Medical University, Guangzhou, 511495, China; Department of Urology, Guizhou Provincial People's Hospital, Key Laboratory for Cancer Prevention and Treatment of Guizhou Province, Guiyang, 550000, China; Guizhou University Medical College, Guiyang, 550025, China; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China; Zunyi Medical University, Zunyi, 563000, China; Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University, Hunan, China展开收起
190
天
PRMT1 and YBX1 cooperatively transcriptionally activate GPX4 to inhibit ferroptosis and promote breast cancer progression
作者
Yu Li; Baowen Yuan; Jiaxiang Liu; Xin Wang; Jingyao Zhang; Ting Hu; Tianyu Ma; Die Zhang; Yinuo Wang; Jingjing Zhang; Jiayi Gao; Tianyang Gao; Xinhui Hao; Chang Guo; Dong Yan; Wei Huang; Yan Wang展开收起
作者单位
State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China; Institute of Cancer Research, Henan Academy of Innovations in Medical Sciences, Zhengzhou, Henan, China展开收起
FAQ
CANCER LETTERS审稿要多久?
截至2026-11-19,CrushSCI 收录了 CANCER LETTERS 的 16 篇完整审稿记录。最快一篇从收稿到录用用了 52 天(ACSL5 drives pancreatic ductal adenocarcinoma by suppressing mitophagy and enhancing ferroptosis resistance via the JAK1-STAT1-OASL axis,2026-07-06 收稿,2026-08-27 录用),最慢一篇用了 267 天;平均 153.5 天,中位数 154 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
